
Join to View Full Profile
1500 Duarte RdDuarte, CA 91010
Phone+1 626-256-4673
Dr. Shouse is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- College of Osteopathic Medicine of the PacificClass of 2012
Certifications & Licensure
- CA State License 2013 - 2027
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma Start of enrollment: 2023 Jan 02
Roles: Principal Investigator, Contact
- Open-label of Loncastuximab Tesirine (ADCT-402) in Relapsed/Refractory Marginal Zone Lymphoma Start of enrollment: 2022 Jun 21
Roles: Principal Investigator
- Safety and Efficacy of ALLO-501A Anti-CD19 Allogeneic CAR T Cells in Adults with Relapsed/Refractory Large B Cell Lymphoma, Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (ALPHA2) Start of enrollment: 2020 May 21
Roles: Contact
Publications & Presentations
PubMed
- Impact of Age on Biology, Presentation and Outcomes in Marginal Zone Lymphoma: Results From a Multicenter Cohort Study.Pallawi Torka, Natalie S Grover, Timothy J Voorhees, Reem Karmali, Kaitlin Annunzio
Hematological Oncology. 2025-05-01 - 1 citationsEvaluation of Ki-67 expression and large cell content as prognostic markers in MZL: a multicenter cohort study.Natalie S Grover, Kaitlin Annunzio, Marcus Watkins, Pallawi Torka, Reem Karmali
Blood Cancer Journal. 2024-10-18 - Outcomes of marginal zone lymphoma treated with ibrutinib in the first-line setting in the United States: a real-world analysis.Narendranath Epperla, Qiuhong Zhao, Tamara Moyo, Marcus P Watkins, Montreh Tavakkoli
Blood Advances. 2024-02-13
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: